Opeolu Adeoye, MD, MS

Professor of emergency medicine at the Washington University in St. Louis.

Articles by Opeolu Adeoye, MD, MS

Efficacy of Adjunctive Therapies for Acute Ischemic Stroke Based on Phase 3 MOST Trial: Opeolu Adeoye, MD, MS; Andrew Barerrto, MD, MS

ByOpeolu Adeoye, MD, MS,Andrew Barerrto, MD, MS

February 26th 2024

The professor of emergency medicine at Washington University in St. Louis and associate professor of neurosurgery at UTHealth Houston talked about results from the phase 3 MOST trial assessing argatroban and eptifibatide in acute ischemic stroke. [WATCH TIME: 3 minutes]

Opeolu Adeoye, MD, MS

Articles by Opeolu Adeoye, MD, MS

Efficacy of Adjunctive Therapies for Acute Ischemic Stroke Based on Phase 3 MOST Trial: Opeolu Adeoye, MD, MS; Andrew Barerrto, MD, MS

Latest Updated Articles

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

Understanding Key Clinical and Genetic Biomarkers in Huntington Disease Research: Sarah O'Shea, MD, MSc

A Step Forward in Multiple System Atrophy: Phase 2 Findings Reinforce ATH434’s Disease-Modifying Potential

De-Escalation Strategies in Multiple Sclerosis: Oral Therapies and Cladribine

COAST Trial: Evaluating Ozanimod Step-Down in Multiple Sclerosis

NeuroVoices: Gerald Maguire, MD, on Raising Awareness of the Neurobiology of Stuttering